Profilo
Mr. Jason G.
Duncan is a Chief Legal & Administrative Officer at Neumora Therapeutics, Inc. and a Software Engineer at American Panel Corp.
Mr. Duncan was previously employed as a General Counsel by Albireo Pharma, Inc., a General Counsel by Stallergenes Greer, Inc., a Vice President, Head-Compliance & Legal by Sobi, Inc., a Vice President, Head-Compliance & Legal by Swedish Orphan Biovitrum AB, and an Associate General Counsel by EMD Serono, Inc. He received his undergraduate degree from Dickinson College and a graduate degree from Suffolk University Law School.
Posizioni attive di Jason G. Duncan
| Società | Posizione | Inizio |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Direttore Amministrativo | 12/12/2023 |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Jason G. Duncan
| Società | Posizione | Fine |
|---|---|---|
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Consigliere Generale | 01/06/2018 |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Responsabile della Conformità | 01/10/2015 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/08/2015 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/07/2014 |
| ALBIREO PHARMA, INC. | Consigliere Generale | - |
Formazione di Jason G. Duncan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Consumer Durables |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Suffolk University Law School
Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Health Technology |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Commercial Services |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
















